Clinical Trials Browser

Active not recruiting × MLN 8237 × Lymphoid × Clear all

NCT01695941 2026-03-18

Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

Phase 1 Active not recruiting

Lymphoma, B-Cell, Lymphoma, Mantle-Cell